Superintendent pharmacist owner suspended after serious misconduct findings including dispensing water instead of Oramorph
Date of Decision: September 17, 2026
Registrant's Role: Pharmacist
Allegations:
- The registrant, while part-owner, Superintendent Pharmacist and frequently Responsible Pharmacist at Harper’s Pharmacy, Brighton, was alleged to have substituted Oramorph/morphine sulphate and/or oxycodone hydrochloride with water or another liquid between January and August 2018.
- The registrant was alleged to have supplied Patient A with liquid that had been substituted for Oramorph/morphine sulphate.
- The registrant was alleged to have acted dishonestly by knowingly supplying medication that did not contain the prescribed medicine.
- The registrant was alleged to have behaved inappropriately during a home visit to Patient A, causing alarm and distress, including entering the patient’s home without consent and asking for the return of a bottle containing a suspected substituted medicine.
- The registrant was alleged to have possessed controlled drugs and prescription-only medicines at home without good reason, including Oramorph, buprenorphine, methylphenidate and stimulant medicines.
- The registrant was alleged to have retained controlled drug registers away from pharmacy premises without good reason and breached patient confidentiality.
- The registrant was alleged to have consumed morphine, oxycodone, cocaine, narcocaine and amphetamine without a valid medical reason.
- The registrant was alleged to have failed to maintain Responsible Pharmacist logs between January and August 2018.
Outcome: 4 month suspension
GPhC Standards Breached:
- Standard 1 – Provide person-centred care
- Standard 5 – Use professional judgement
- Standard 6 – Behave in a professional manner
- Standard 7 – Respect and maintain the person’s confidentiality and privacy
Case Summary
Allegations
This case concerned a pharmacist who was the part-owner and Superintendent Pharmacist of Harper’s Pharmacy in Brighton during the period January to August 2018.
The concerns arose after Patient A, who was prescribed Oramorph (morphine oral solution) for pain associated with a prolapsed disc, reported concerns that medication supplied by the pharmacy did not contain the expected medicine.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.
